Sort
48,018 grants matching “immunotherapy”
Immunosuppression and Metabolic Rewiring in Tumor-infiltrating Neutrophils
$361,953Xin Lu · University Of Notre Dame · R01 · FY2023 · CA
Development of tolerogenic dendritic cell-based immunotherapies and restorative insulin approaches to alleviate type 1 diabetes
$361,945Michael W Lipscomb · Howard University · SC1 · FY2018 · GM
Role of exosomal SPHK1 in ovarian cancer progression
$361,942Sunila Pradeep · Medical College Of Wisconsin · R01 · FY2025 · CA
Quantitative Systems Biomedicine and Pharmacology for Multiscale Tissue Damage
$361,930Ashlee Nicole Ford Versypt · State University Of New York At Buffalo · R35 · FY2021 · GM
Innate and Adaptive Anti-Myeloma Immunity
$361,924Nikhil C. Munshi · Dana-Farber Cancer Inst · P01 · FY2014 · CA
HSP90 AS A TARGET FOR MECHANISM-BASED THERAPY FOR CASTRATION-RESISTANT PROSTATE C
$361,919Neal Rosen · Sloan-Kettering Inst Can Research · P50 · FY2010 · CA
Structural Studies of a T cell Specific Tyrosine Kinase
$361,894Amy H Andreotti · Iowa State University · R01 · FY2015 · AI
Development of Long non-coding RNA-directed Target Therapy for Triple-Negative Breast Cancer
$361,866Chunru Lin · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA
Stimulating Lymphocyte Activation Combined with Inhibition of Immunosuppressive Signals in Colon Cancer Metastases
$361,836Ajay V. Maker · University Of California, San Francisco · R37 · FY2025 · CA
Regulation of Death Ligand-Induced Killing
$361,829Scott H Kaufmann · Mayo Clinic Rochester · R01 · FY2019 · CA
Requirement for sensitive T cell response to antigen
$361,780Michael L Dustin · New York University School Of Medicine · R37 · FY2014 · AI
Plasma Membrane Proteins in Myeloid-Derived Suppressor Cells
$361,776Catherine C. Fenselau · Univ Of Maryland, College Park · R01 · FY2012 · GM
Mechanisms of selective therapeutic synergy of PARP-inhibition and CTLA4 blockade engaged by interferon-gamma in the ovarian tumor microenvironment
$361,703Sarah Foster Adams · University Of New Mexico Health Scis Ctr · R37 · FY2019 · CA
MYC activation in tumor progression of neuroblastoma
$361,698Min Hee Kang · Texas Tech University Health Scis Center · R01 · FY2019 · CA
Improved therapy for p53wt melanoma by functionally restoring the CDKN2A pathway
$361,688Ann Richmond · Vanderbilt University · R01 · FY2019 · CA
Cellular Immunity/JC Virus/AIDS/Leukoencephalopathy
$361,663Igor J Koralnik · Beth Israel Deaconess Medical Center · R01 · FY2009 · NS
T cell immunity to cytomegalovirus in tissues and circulation
$361,643Donna L Farber · Columbia University Health Sciences · U19 · FY2021 · AI
Protein Structure/Function by NMR, Crystallography and Computational Chemistry
$361,596Eric Oldfield · University Of Illinois At Urbana-Champaign · R01 · FY2010 · AI
Recognition of bacterial antigens by NKT cells
$361,588Mitchell Kronenberg · La Jolla Institute For Immunology · R01 · FY2009 · AI
Recognition of bacterial antigens by NKT cells
$361,588Mitchell Kronenberg · La Jolla Institute For Immunology · R01 · FY2008 · AI
Analysis of Lag-3 in Regulatory T cell Function
$361,537Johns Hopkins University · R01 · FY2004 · AI
A Novel Positron Emission Tomography Strategy for Early Detection and Treatment Monitoring of Graft-versus-host Disease
$361,522Michelle Louise James · Stanford University · R01 · FY2020 · CA
A Novel Positron Emission Tomography Strategy for Early Detection and Treatment Monitoring of Graft-versus-host Disease
$361,504Sanjiv S Gambhir · Stanford University · R01 · FY2017 · CA
A Novel Positron Emission Tomography Strategy for Early Detection and Treatment Monitoring of Graft-versus-host Disease
$361,499Sanjiv S Gambhir · Stanford University · R01 · FY2016 · CA
Molecular Targeted Radionuclide Therapy to Enhance Tumor Cell Susceptibility and Response to Immune Checkpoint Inhibition
$361,468Zachary Scott Morris · University Of Wisconsin-Madison · P01 · FY2024 · CA